Abstract:Objective To investigate the influence of recombinant human granulocyte colony stimulating factor (rhG-CSF) on CD34+ hematopoietic stem cells and regulatory T cells in healthy donors.Method Seventy-five healthy donors were retrospectively analyzed in this study,including 65 related donors and 10 unrelated donors.All the donors were mobilized with rhG-CSF (5-7.5 μg·kg-1 ·d-1).Blood routine and the percentage of CD34+ stem cells in peripheral blood were monitored during mobilization.Bone marrow stem cells on day 4,and peripheral blood stem cells on day 5 and/or 6 were collected for related donors.Peripheral blood stem cells were collected on day 5 for unrelated donors.Flow cytometry was used to detect CD34+ cells,total T lymphocytes (CD3+),and regulatory T cells (CD4+ CD25 + CD127-).Result After rhG-CSF mobilization,the percentage of CD34+ stem cells was 0.13％ ± 0.07％ in bone marrow harvests,and 0.36％ ± 0.21％ in peripheral blood products (u =7.167,P＜0.001).When converted to absolute number,the CD34+ cells were (53.25 ± 33.59)/μl in bone marrow harvests,which was significantly lower than that (874.33 ± 540.15)/μl in peripheral blood products (u =6.714,P＜0.001).The percentage of regulatory T cells was 0.81％ (0.40％,6.09％) in bone marrow harvests,and 1.03％ (0.41％,5.70％) in peripheral blood products,without significant difference (u =0.131,P =0.894).The absolute number of regulatory T cells was obviously lower in bone marrow harvests (129.12 ± 100.90)/μl than in peripheral blood products (3357.34 ± 2831.72)/μl (u =6.389,P＜0.001).Although the absolute number of T cells was higher in peripheral blood products (51 221.92 ± 17 128.01)/μl than in bone marrow harvests (2 101.82 ± 1 288.93)/μl (u =6.784,P＜0.001),no significant difference was detected for regulatory T cells/total T cells ratio (0.069 ± 0.048 versus 0.067 ± 0.048/μl;t =0.211,P =0.833).Conclusion High frequency and absolute number of CD34+ stem cells in peripheral blood harvests may be partially associated with rapid hematopoietic reconstitution after transplantation.Similar regulatory T cells/total T cells ratio may contribute to the similar occurrence of acute graft versus host disease.

Effect of Recombinant Human Granulocyte Colony-Stimulating Factor on T-Lymphocyte Function and the Mechanism of This Effect

[Study on the in Vivo Effect of Rhg-Csf on Peripheral T Lymphocyte].

Recombinant Human Granulocyte Colony-Stimulating Factor Significantly Decreases the Expression of CXCR3 and CCR6 on T Cells and Preferentially Induces T Helper Cells to a T Helper 17 Phenotype in Peripheral Blood Harvests.

In Vivo Induction of T-cell Hyporesponsiveness and Alteration of Immunological Cells of Bone Marrow Grafts Using Granulocyte Colony-Stimulating Factor.

Modulation of Adhesion Molecule Expression on T Cells in Bone Marrow after in Vivo Rhg-Csf Application

Granulocyte colony-stimulating factor directly acts on mouse lymphoid-biased but not myeloid-biased hematopoietic stem cells

[Effects of Rhg-Csf Mobilization on Immunological Properties of Grafts from Peripheral Blood and Bone Marrow].

Influence of Recombinant Human Granulocyte Colony Stimulating Factor (Rhg-Csf) on CD34+ Hematopoietic Stem Cells and Regulatory T Cells in Healthy Donors

Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation

Effects of Granulocyte Colony-Stimulating Factor on Proliferation and Apoptosis of B Cells in Bone Marrow of Healthy Donors

Effects of Rhg-Csf Mobilization on Th17 Cells in Donors' Peripheral Blood and Bone Marrow Grafts

Directs effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on adaptive immunogenesis

G-CSF MODULATES CYTOKINE PROFILE OF DENDRITIC CELLS AND DECREASES ACUTE GRAFT-VERSUS-HOST DISEASE THROUGH EFFECTS ON THE DONOR RATHER THAN THE RECIPIENT

Effects of rhG-CSF mobilization on immunological characteristics of peripheral blood grafts and steady-state bone marrow

Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood.

Associations of Granulocyte Colony-Stimulating Factor with Toxicities and Efficacy of Chimeric Antigen Receptor T-cell Therapy in Relapsed or Refractory Multiple Myeloma

Recombinant Human Granulocyte Colony-Stimulating Factor after Allogeneic Bone Marrow Transplantation.

CD19+CD24highCD38high B Cells Exhibit Higher Ability in TGF-β and IL-10 Secretion and Suppressing of CD4+ T Cell Proliferation but Are Quantitatively Decreased in G-BM of Healthy Donors (P2146)

Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.

Investigation on related factors of CD 34+ cells in peripheral blood mobilization effect by G-SCF stimulation

[CD34 Cells and T Cell Subsets in Recombinant Human Granulocyte Colony-Stimulating Factor Primed Bone Marrow Grafts from Donors with Different Characteristics].